0.00Open0.00Pre Close0 Volume0 Open Interest68.00Strike Price0.00Turnover117.97%IV-15.50%PremiumDec 13, 2024Expiry Date12.47Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9764Delta0.0080Gamma6.41Leverage Ratio-0.0680Theta0.0036Rho6.26Eff Leverage0.0033Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet